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Answer
Epstein–Barr virus (EBV)-associated smooth muscle tumor
at the infrascapular fossa.
The EBV, a member of the herpesvirus family, is highly
prevalent within the human population. It has been
implicated in the pathogenesis of hematological, epithelial,
and mesenchymal tumors. EBV-associated smooth muscle
tumors (EBV-SMT) are related to an immunocompromised
or immunosuppressed state.
Soft tissue tumors occurring secondary to an immunocom-
promised state were not recognized before 1970 [1]. It was
only in 1995 that the association between smooth muscle
tumors and EBV was established in patients who had
undergone organ transplantation [2, 3]. These lesions are
rarely diagnosed less than 3 months post-transplant and have
been reported 29 years after renal transplantation [4]. They
have an unusual predilection to occur in sites that have little
smooth muscle, such as the brain or dura. Other sites of
involvement include the adrenal gland, lung, gallbladder,
bone, bladder, spleen, thyroid, and heart [5]. Multiple sites of
involvement can occur in up to 68% [5]. In such cases,
clonal analyses suggest that they arise from separate
infection events rather than a metastatic phenomenon [2].
Radiologically, EBV-SMT frequently present as a non-
specific enhancing soft tissue mass. Appearance can range
from a vividly enhancing mass [6] to a more heterogeneous
enhancing lesion [7]. MRI is sensitive to the detection of
these tumors, but is not specific. The key to narrowing the
diagnosis is an immunodeficient or an immunocompro-
mised state, as in this patient.
A complete consensus on criteria for malignancy in deep
smooth muscle tumors has not been established, but most
experts suggest that the presence of cytologic atypia and
mitotic activity (>1 mitotic figure per 50 high power fields)
should raise suspicion of malignancy [8–10]. EBV-SMT,
which often demonstrates mitotic activity and primitive
round cell areas that may be mistaken for atypia, could
potentially lead to a misdiagnosis of leiomyosarcoma.
Multifocality in EBV-SMT may further suggest metastasis
and thus malignancy. The prognosis of leiomyosarcomas of
somatic soft tissues is generally poor, with approximately
50% 5-year survival, often influenced by tumor size. How-
ever, the prognosis of EBV-SMT (though based on relatively
few cases) is usually good and related to the immune status
of the patient rather than tumor size [5]. Consequently,
recognition of this entity is crucial to the patient.
Epstein–Barr virus smooth muscle tumors are a rare entity.
Other conditions that might be considered in the differential
diagnosis of this case include a peripheral nerve sheath tumor
(PNST), given the close proximity to the spinoglenoid notch
where the suprascapular nerve is located. There are, however,
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no features of denervation within the infraspinatus muscle
such as may accompany suprascapular nerve involvement
[11]. Extramedullary relapse of ALL is also a concern
because of the patient’s medical history. The main sites of
extramedullary relapses of acute leukemia are the central
nervous system and skin, although leukemic infiltrates may
relapse at other sites including the neck, spine, limbs, and
body cavity [12].
However, in view of the clinical context of an immuno-
deficient or immunocompromised state, EBV-associated
smooth muscle tumor should also be entertained.
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